Keros Therapeutics, Inc. (KROS)
10.50
-0.05
(-0.47%)
USD |
NASDAQ |
Jun 03, 16:00
10.49
-0.01
(-0.10%)
Pre-Market: 19:59
Keros Therapeutics Market Cap : 207.19M for June 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PTC Therapeutics, Inc. | 5.692B |
| Sarepta Therapeutics, Inc. | 1.714B |
| Insmed, Inc. | 22.49B |
| United Therapeutics Corp. | 23.16B |
| Enanta Pharmaceuticals, Inc. | 326.65M |
Market Cap Related Metrics
| PS Ratio | 10.13 |
| PEG Ratio | -0.0023 |
| Price to Book Value | 0.7254 |
| Price | 10.50 |
| Earnings Yield | -28.62% |
| PEGY Ratio | -0.0023 |